نتائج البحث - "glucose cotransporter"

1

Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial

المؤلفون: Søren Gullaksen, Liv Vernstrøm, Steffen S. Sørensen, Steffen Ringgaard, Christoffer Laustsen, Kristian L. Funck, Per L. Poulsen, Esben Laugesen

المصدر: Gullaksen, S, Vernstrøm, L, Sørensen, S S, Ringgaard, S, Laustsen, C, Funck, K L, Poulsen, P L & Laugesen, E 2023, ' Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial ', Diabetologia . https://doi.org/10.1007/s00125-023-05876-wTest
Gullaksen, S, Vernstrøm, L, Sørensen, S S, Ringgaard, S, Laustsen, C, Funck, K L, Poulsen, P L & Laugesen, E 2023, ' Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes : a randomised trial ', Diabetologia, vol. 66, no. 5, pp. 813-825 . https://doi.org/10.1007/s00125-023-05876-wTest

مصطلحات موضوعية: Sodium–glucose cotransporter 2 inhibitor, Endocrinology, Diabetes and Metabolism, Internal Medicine, Glucagon-like peptide-1 receptor agonist, Type 2 diabetes, Kidney, MRI

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c5188c3e76db03c71b452e310cc0dadTest
https://pure.au.dk/portal/da/publications/separate-and-combined-effects-of-semaglutide-and-empagliflozin-on-kidney-oxygenation-and-perfusion-in-people-with-type-2-diabetes-a-randomised-trialTest(14a29f75-2fdd-48d6-92b2-d24bcaaa926b).html

2

Cardioprotective mechanisms of sodium-glucose cotransporter 2 inhibitors

المؤلفون: Ashot Musaelovich Mkrtumyan, Nadezhda K. Mishchenko, T. N. Markova

المصدر: Сахарный диабет, Vol 24, Iss 3, Pp 291-299 (2021)

مصطلحات موضوعية: RC620-627, Chemistry, Endocrinology, Diabetes and Metabolism, high-sensitivity troponin i, sodium/hydrogen exchanger, sodium-glucose cotransporter 2 inhibitors, Pharmacology, ketogenesis, Endocrinology, n-terminal pro-b-type natriuretic peptide, Sodium/Glucose Cotransporter 2, Internal Medicine, Nutritional diseases. Deficiency diseases, cardiovascular effects

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd5593c7921205506335d95f5aa5d3b7Test
https://www.dia-endojournals.ru/jour/article/view/12541Test

3

Sodium–glucose cotransporter 2 inhibitors in type 2 diabetes patients with renal function impairment slow the annual renal function decline, in a real clinical practice

المؤلفون: Keiji Shimada, Munehiro Kitada, Taro Hirai, Yoshio Ogura, Masaru Sakurai, Mizue Fujii, Yuta Takagaki, Kazunori Konishi, Atsushi Nakagawa, Daisuke Koya, Itaru Monno, Yoshihiro Hayashi, Erina Oda

المصدر: Journal of Diabetes Investigation, Vol 12, Iss 9, Pp 1577-1585 (2021)
Journal of Diabetes Investigation

مصطلحات موضوعية: Blood Glucose, Male, Sodium–glucose cotransporter 2 inhibitor, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Urology, Renal function, Type 2 diabetes, 030204 cardiovascular system & hematology, Egfr decline, Kidney, Annual change, Diseases of the endocrine glands. Clinical endocrinology, 03 medical and health sciences, 0302 clinical medicine, Diabetes mellitus, Internal Medicine, Medicine, Humans, Diabetic Nephropathies, 030212 general & internal medicine, Practice Patterns, Physicians', Diabetic kidney disease, Sodium-Glucose Transporter 2 Inhibitors, Aged, Retrospective Studies, business.industry, General Medicine, Articles, medicine.disease, Prognosis, RC648-665, Clinical Practice, Clinical Science and Care, Diabetes Mellitus, Type 2, Sodium/Glucose Cotransporter 2, Albuminuria, Original Article, Female, medicine.symptom, business, Annual estimated glomerular filtration rate decline, Biomarkers, Follow-Up Studies, Glomerular Filtration Rate

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da5d0d77fff98537c2f3b5a129ad1353Test
https://doaj.org/article/b15014c99b144c01b71d312f5adb526fTest

4

Dapagliflozin in the treatment of patients with heart failure with reduced left ventricular ejection fraction – a practical approach

المؤلفون: Jadwiga Nessler

المصدر: Advances in Interventional Cardiology, Vol 17, Iss 2, Pp 135-140 (2021)
Postępy w Kardiologii Interwencyjnej = Advances in Interventional Cardiology

مصطلحات موضوعية: medicine.medical_specialty, law.invention, chemistry.chemical_compound, Mineralocorticoid receptor, Randomized controlled trial, law, Internal medicine, patients’ clinical profiles, Medicine, flozins – sodium-glucose cotransporter type 2 (SGLT-2) inhibitors (SGLT-2), Dapagliflozin, Survival rate, heart failure with reduced left ventricular ejection fraction (hfref), Aldosterone, Ejection fraction, biology, business.industry, Angiotensin-converting enzyme, indications for use, dapagliflozin, medicine.disease, chemistry, Heart failure, biology.protein, Cardiology, flozins – sodium-glucose cotransporter type 2 (sglt-2) inhibitors (sglt 2), Special Paper, Cardiology and Cardiovascular Medicine, business